Valuation: DexCom, Inc.

Capitalization 23.39B 19.85B 18.15B 17.16B 31.99B 2,209B 32.29B 215B 84.01B 1,060B 87.74B 85.89B 3,663B P/E ratio 2026 *
25x
P/E ratio 2027 * 20.9x
Enterprise value 22.93B 19.46B 17.8B 16.83B 31.36B 2,166B 31.66B 211B 82.37B 1,040B 86.03B 84.22B 3,592B EV / Sales 2026 *
4.39x
EV / Sales 2027 * 3.77x
Free-Float
93.28%
Yield 2026 *
-
Yield 2027 * -
1 day-0.49%
1 week-1.21%
Current month+1.78%
1 month-7.89%
3 months-13.38%
6 months+10.20%
Current year-8.68%
1 week 58.7
Extreme 58.7
61.63
1 month 56.72
Extreme 56.72
66.14
Current year 56.72
Extreme 56.72
75.98
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5d. change 1-year change 3-years change Capi.($)
-0.49%-1.21%-28.98%-49.57% 23.39B
-3.09%-5.75%-36.72%-23.52% 147B
-2.32%-4.81%-8.78%-15.01% 97.77B
-0.15%-1.29%+54.24%+82.34% 58.67B
+2.12%-14.12%-7.75%+55.17% 50.8B
-2.50%+0.08%-10.64%-40.14% 42.55B
-5.59%-11.69% - - 33.42B
+1.21%+8.39%+52.97%-9.90% 23.03B
-2.92%-3.24%-8.38%+10.86% 20.35B
-0.79%+4.40%-19.21%-33.47% 18.74B
Average -1.45%-2.92%-1.47%-2.58% 51.56B
Weighted average by Cap. -1.81%-4.49%-8.10%-1.64%

Financials

2026 *2027 *
Net sales 5.23B 4.44B 4.06B 3.84B 7.15B 494B 7.21B 48.1B 18.77B 237B 19.61B 19.19B 819B 5.85B 4.96B 4.54B 4.29B 8B 553B 8.07B 53.83B 21.01B 265B 21.94B 21.48B 916B
Net income 966M 820M 750M 709M 1.32B 91.28B 1.33B 8.89B 3.47B 43.81B 3.62B 3.55B 151B 1.17B 996M 911M 861M 1.6B 111B 1.62B 10.8B 4.22B 53.21B 4.4B 4.31B 184B
Net Debt -456M -387M -354M -335M -624M -43.1B -630M -4.2B -1.64B -20.69B -1.71B -1.68B -71.46B -1.35B -1.14B -1.04B -987M -1.84B -127B -1.86B -12.38B -4.83B -61B -5.05B -4.94B -211B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-05-08 60.61 $ -0.49% 4,217,962
26-05-07 60.91 $ +0.91% 5,080,786
26-05-06 60.36 $ +1.48% 5,905,337
26-05-05 59.48 $ -0.93% 5,528,661
26-05-04 60.04 $ -2.14% 5,492,762
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
60.61USD
Average target price
83.54USD
Spread / Average Target
+37.83%

Quarterly revenue - Rate of surprise